期刊文献+

病程和体重对2型糖尿病胰岛功能的影响 被引量:16

The effects of disease duration and body weight on insulin secretion ability in type 2 diabetes
下载PDF
导出
摘要 目的:分析病程和体重对2型糖尿病患者胰岛素分泌能力的影响。方法:以横断面研究的方法,分析不同病程组3个胰岛素分泌指数(HOMA-β、INSR30、INSR120)与初诊断组的变化,并比较超重和肥胖患者的3个胰岛素分泌指数和相同病程非肥胖患者的差异。结果:胰岛素分泌功能随病程延长而逐步衰退,与初诊断组相比,病程超过2年后统计学差异显著。超重和肥胖患者的胰岛素分泌能力强于同病程的非肥胖患者,但病程达15年以上时这种差异消失。病程2~4年的超重和肥胖患者INSR30、INSR120与初诊断组比较分别升高9.40%、5.39%,与非肥胖患者的胰岛素分泌能力有显著性差异。结论:2型糖尿病患者胰岛素分泌能力随病程延长而逐步衰退,超重和肥胖患者的分泌能力和随病程变化模式与非肥胖患者间存在差异。 Objective:To evaluate the effects of disease duration and body weight on insulin secretion in type 2 diabetes.Methods:Type 2 diabetic patients were divided to groups according to the disease duration,and three insulin secretion indices(HOMA-β,INSR30,INSR120) of all groups were compared with the newly diagnosed group and the parameters in overweight / obese patients were compared with non-obese patients with same disease duration.Results:The insulin secretion ability decreased gradually as the disease duration extended.The statistical differences appeared when the disease duration exceeded 2 years.Insulin secretion was significantly higher in overweight / obese patients than that of non-obese one with the same disease duration.INSR30 and INSR120 increased 9.40% and 5.39% in overweight / obese patients with 2 to 4 years diabetes,respectively,when compared with newly onset group.Conclusion:Insulin secretion ability decreases with type 2 diabetes duration.There are differences of both insulin secretion ability and mode of change between overweigh / obese patients and non-obese one.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第12期1792-1796,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省科技支撑计划(社会发展)重点项目(BE2009687 BE2009613)
关键词 2型糖尿病 胰岛 病程 体重 type 2 diabetes islet disease duration body weight
  • 相关文献

参考文献19

  • 1King H,Aubert RE, Herman WH. Global burden of dia- betes, 1995-2025 : Prevalence, numerical estimates, andprojections[J]. Diabetes Care, 1998,21(9) : 1414-1431.
  • 2International Diabetes Federation. Diabetes Atlas 2000 [ R ].Brussels, Belgium: International Diabetes Federation, 2001.
  • 3Yang WY, Lu JM, Weng JP, et al. Prevalence of Diabetes among men and women in China [J]. N Engl J Med, 2010,362(12) : 1090-1101.
  • 4Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta- cell function in human subjects. Evidence for a hyperbolic function[J]. Diabetes, 1993,42(11) : 1663-1672.
  • 5Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes[J]. Diabetologia, 2003,46( 1 ) :3-19.
  • 6Rudenski AS,Hadden DR,Atkinson AB,et al. Natural history of pancreatic islet b-cell function in type 2 dia- betes mellitus studies over six years by homeostasis mod- el assessment [J]. Diabet Med, 1988,5 ( 1 ) : 36-41.
  • 7UKPDS Study Group. Overview of 6 years' therapy of type II diabetes : a progressive diseaSe (UKPDS 16) [ J]. Diabetes, 1995,44( 11 ) : 1249-1258.
  • 8Prando R,Odetti P,Melga P,et al. Progressive deteriora- tion of beta-cell function in nonobese type 2 diabetic sub- jects[J]. Diabetes Metab, 1996,22(3) : 185 - 191.
  • 9Ostgren CJ,Lindblad U,Ranstam J,et al. Glycaemic con- trol,disease duration and b-cell function in a Swedish community:Skaraborg hypertension and diabetes project [J]. Diabet Med,2002,19(2) : 125-129.
  • 10Matthews DR, Hosker JP, Rudenski AS, et al. Homeosta- sis model assessment:insulin resistance and B-cell func- tion from fasting plasma glucose and insulin concentra- tions in man[J]. Diabetologia, 1985,28(7) :412-419.

同被引文献154

引证文献16

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部